Willingness of pay as a measure of benefit in health;La mesure du benefice en sante par la methode du consentement a payer

Journal d'Economie Medicale

Volumn 17, Issue 5, 1999, Pages 301-326

  Allenet, B ^a   Sailly, J C ^a  

^a CNRS   (France)

Author keywords

Benefit; Contingent valuation; Cost benefit; Willingness to pay

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; FRANCE; HEALTH CARE COST; HEALTH ECONOMICS;

EID: 0032846902     PISSN: 02940736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Grossman M. On the Concept of Health Capital and the Demand for Health. Journal of Political Economy 1972;80:223-255.
2. Muurinen J-M. Demand for Health. Journal of Health Economics 1982;1:5-28.
3. e série, 8.
4. Picard P. Eléments de microéconomie, Théorie et application. Montchrétien 1992: 471-474.
5. Gafni A. Using Willingness-to-Pay as Measure of Benefits: What is the Relevant Question to Ask in the Context of Public Decision-Making about Health Care Programs. Medical Care 1991;29:1246-1252.
6. O'Brien B, Gafni A. When Do the «Dollars» Make Sense? Toward a Conceptual Framework for Contingent Valuation Studies in Health Care. Medical Decision Making 1996;16:288-299.
7. Kealy MJ, Turner RW. A Test of the Equality of Closed-Ended and Open-Ended Contingent Valuations. American Journal of Agricultural Economics 1993;75:321-331.
8. Mitchell RC, Carson RT. Using Surveys to Value Public Goods. Washington DC : Ressources for the Future ; Draft Report to US EPA Office of Strategic Assessment, 1989.
9. Randall A, Ives BC, Eastman C. Bidding Games for Valuation of Aesthetic Environmental Improvements. Journal of Environmental Economics and Management 1974;1:132-149.
10. Mitchell RC, Carson RT. An Experiment in Determining WTP for National Water Quality Improvements. Washington DC : Ressources for the Future ; Draft Report to US EPA Office of Strategic Assessment, 1981.
11. Bishop RC, Heberlein TA. Measuring Values of Extra-Market Goods : Are Indirect Measures Biased ? American Journal of Agricultural Economics 1979;69:926-930.
12. Sellar C, Stoll JR, Chavas JP. Validation of Empirical Measures of Welfare Change : A Comparison of Non-Market Techniques. Land Economics 1985;61;2:156-175.
13. Samples KC. A Note on the Existence of Starting Point Bias in Iterative Bidding Games. West J Agr Econom 1985;10:32-40.
14. Boyle KJ, Bishop RC, Welsh MP. Starting Point Bias in Contingent Valuation Bidding Games. Land Economics 1985;61;2:188-194.
15. Hanley N. Using Contingent Valuation to Environmental Improvements. Applied Economics 1988;20:541-549.
16. Schulze WD, D'Arge RC, Brookshire DS. Valuing Environmental Commodities : Some Recent Experiments. Land Economics 1981;57:151-172.
17. Bonnieux F. La méthode d'évaluation contingente. INRA, 1992, 38 p.
18. Bergstrom JC, Stoll JR, Randall A. Information Effects in Contingent Markets. American Journal of Agricultural Economics 1989;71;3:685-691.
19. Gouriéroux C. Econométrie des variables qualitatives. Economica, Paris, 1984, 356 p.
20. Acton JP. Evaluation of public programmes to save lives : the case of heart attacks. Report R950RC, Rand Corporation, Santa Monica, CA, 1973
21. Allenet B. La mesure du bénéfice en santé par la méthode de l'évaluation contingente : application au domaine du médicament. Thèse pour le Doctorat en Sciences Economiques, Université Claude Bernard - Lyon I, 1996.
22. Thompson MS. Read JL, Liang M. Feasibility of Willingness-to-Pay Measurement in Chronic Arthritis. Medical Decision Making 1984;4;2:197-215.
23. Thompson MS. Willingness to Pay and Accept Risks to Cure Chronic Disease. American Journal of Public Health 1986;76;4:392-396.
24. O'Brien B, Viramontes JL. Willingness to Pay : A Valid and Reliable Measure of Health State Preference ? Medical Decision Making 1994;14:289-297.
25. Berwick DM, Weinstein MC What Do Patients Value ? Willingness to Pay for Ultrasound in Normal Pregnancy. Medical Care 1985;23;7:881-893.
26. Donaldson C. Willingness-to-pay For Publicly-Provided Goods. A Possible Measure of Benefit ? Journal of Health Economics 1990;9:103-118.
27. Golan EH, Shechter M. Contingent Valuation of Supplemental Health Care in Israel. Medical Decision Making 1993;13:302-310.
28. Johannesson M, Aberg H, Agreus L, Borgquist L, Jönsson B. Cost-Benefit Analysis of Non-Pharmacological Treatment of Hypertension. Journal of Int Medicine 1991;230:307-312.
29. Johannesson M, Johansson P, Kristrôm B, Gerdtham UG. Willingness to Pay for Antihypertensive Therapy - Further Results. Journal of Health Economics 1993;12:95-108.
30. Johannesson M, Johansson P, Kristrôm B. et al. Willingness to Pay for Lipid Lowering : A Health Production Function Approach. Applied Economics, 1993;25: 1023-1031.
31. Chestnut LG, Keller LR, Lambert WE. et al. Measuring Heart Patients' Willingness to Pay for Changes in Angina Symptoms. Medical Decision Making 1996;16:65-77.
32. Kartman B, Andersson F, Johannesson M Willingness to Pay for Reduction in Angina Pectoris Attacks. Medical Decision Making 1996;16:248-253.
33. Reardon G, Pathak DS. Assessment of Contingent Valuation Technique with Utility Estimation Models. Journal of Research in Pharmaceutical Economics 1989;1:67-89.
34. Neumann PJ, Johannesson M. The Willingness to Pay for In Vitro Fertilization : a Pilot Study Using Contingent Valuation. Medical Care 1994;28:324-334.
35. Eastaugh S. Valuation of Benefits of Risk-Free Blood. International Journal of Technologies Assessment in Health Care 1991;7;1:51-57.
36. Appel LJ, Steinberg EP, Powe NR. et al. Risk Reduction From Low Osmolarity Contrast Media : What Do Patients Think It is Worth ? Medical Care 1990;29:324-337.
37. O'Brien B. et al. Assessing the Economic Value of a New Antidepressant ; A Willingness to Pay Approach. PharmacoEconomics 1995;8;1:34-45.
38. Drummond MF. Welfare Economics and Cost Benefit Analysis in Health Care. Scottish Journal of Political Economy 1981;28;2.
39. National Oceanic and Atmospheric Administration. Report of the NOAA panel on contingent valuation. Fed. Reg. 1993;58: 4601-4614.
40. Allenet B. Economic Appraisal of a New Treatment of Narcolepsy : Validity of the Willingness-to-Pay Approach. Health and System Science 1998;1-2:61-78.